MDS 2014 PPMI Presentations are Live

The PPMI presentations and posters from the International Parkinson and Movement Disorders Society?s 18th annual congress are now available in Presentations.  The congress was held June 8-12, 2014 in Stockholm, Sweden.  These presentations cover the latest research using PPMI data, images, and biospecimens.

In addition, PPMI’s principal investigator Ken Marek held a breakfast during the conference to update researchers on the current status of the study.  This PPMI Breakfast Status Update is also available.

Degeneration of Corticostriatal Fibers in Parkinson?s Disease and their Differential Relations to Cognitive and Motor Deficits – Zhang, Y; Wu, K; Buckley, S; Mendick, S; Seibyl, J; Foster, E;  Coffey, C; Marek, K; Schuff; N; The Parkinson?s Progression Markers Initiative

What Do We Now Know About Alpha-Synuclein’s Role In Parkinson’s Disease Pathology? – Trojanowski,  J.Q.

The Parkinson’s Progression Marker Initiative (PPMI) ? Assessment Of Clinical, Imaging And CSF PD Biomarkers – The Parkinson’s Progression Markers Initiative

Multicenter Evaluation Of Parkinson’s Disease Progression Using 123- I I-Ioflupane SPECT: Update From The Parkinson’s Progression Marker Initiative Trial – Seibyl,  J; Jennings,  D; Coffey,  C; Marek,  K

Mild Cognitive Impairment and Neuropsychiatric Symptoms in Early, Untreated Parkinson Disease: Results from the PPMI Study – Weintraub,  D; Simuni,  T; Coffey,  C; Caspell-Garcia,  C; Foster,  E; Barone,  P; Leverenz,  J; Burn,  D; Eberling,  J; Chahine,  L; Litvan,  I; Troyer,  M; Siderowf,  A; Aarsland,  D; Hawkins,  K; The PPMI Cognitive Behavioral Working Group; The Parkinson’s Progression Marker Initiative

Excessive Day Time Sleepiness is Not Part of Parkinson’s Disease Disability in De Novo Patients: Results from the PPMI Study – Simuni,  T; Caspell-Garcia,  C; Coffey,  C; Chahine,  L.C; Lasch,  S; Oertel,  W; Marek,  K for the PPMI Sleep Working Group; The Parkinson’s Progression Markers Initiative

Can We Reliably Establish Parkinson’s Disease Subtypes In De Novo Patients: Results From The PPMI Study – Simuni,  T; Caspell-Garcia, C; Coffey,  C; Uribe,  L; Lasch,  S; Jennings,  D; Tanner,  C; Marek,  K; The Parkinson’s Progression Markers Initiative